Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2019
Allogeneic Hematopoietic Cell Transplantation Provides No Benefit for Patients With Hypodiploid Acute Lymphoblastic Leukemia
Michael J Burke
Oncolytic Virotherapy
|
September 24, 2016
Oncolytic Seneca Valley Virus: past perspectives and future directions
Michael J Burke
Future Oncology (London, England)
|
July 2, 2014
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia
Michael J Burke
Health Facilities Management
|
November 26, 2008
Drug free: How North Memorial tackled its pharmaceutical waste problem
Michael J Burke
The New England Journal of Medicine
|
January 21, 2016
Minimal Residual Disease in NPM1-Mutated AML
Michael J Burke
Pediatric Blood & Cancer
|
October 22, 2008
Treatment of a CNS relapse while on therapy for Burkitt lymphoma
Michael J Burke, Vanessa Dayton
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
June 7, 2006
Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist
Michael J Burke, Jana Lincoln
Frontiers in Pediatrics
|
May 27, 2014
Epigenetic modifications in pediatric acute lymphoblastic leukemia
Michael J Burke, Teena Bhatla
Pediatric Blood & Cancer
|
August 11, 2006
Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma
Michael J Burke, Susan L Cohn
The Journal of ECT
|
September 8, 2006
Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression
Michael J Burke, Mustafa M Husain
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2019
Allogeneic Hematopoietic Cell Transplantation Provides No Benefit for Patients With Hypodiploid Acute Lymphoblastic Leukemia
Michael J Burke
Oncolytic Virotherapy
|
September 24, 2016
Oncolytic Seneca Valley Virus: past perspectives and future directions
Michael J Burke
Future Oncology (London, England)
|
July 2, 2014
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia
Michael J Burke
Health Facilities Management
|
November 26, 2008
Drug free: How North Memorial tackled its pharmaceutical waste problem
Michael J Burke
The New England Journal of Medicine
|
January 21, 2016
Minimal Residual Disease in NPM1-Mutated AML
Michael J Burke
Pediatric Blood & Cancer
|
October 22, 2008
Treatment of a CNS relapse while on therapy for Burkitt lymphoma
Michael J Burke, Vanessa Dayton
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
June 7, 2006
Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist
Michael J Burke, Jana Lincoln
Frontiers in Pediatrics
|
May 27, 2014
Epigenetic modifications in pediatric acute lymphoblastic leukemia
Michael J Burke, Teena Bhatla
Pediatric Blood & Cancer
|
August 11, 2006
Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma
Michael J Burke, Susan L Cohn
The Journal of ECT
|
September 8, 2006
Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression
Michael J Burke, Mustafa M Husain
Page
of 12